Evaluation of deficiency of 21-hydroxylation in patients with congenital adrenal hyperplasia.
D000312:Adrenal Hyperplasia, Congenital; D000308:Adrenocortical Hyperfunction / Q000188:drug therapy / Q000201:enzymology*; D000324:Adrenocorticotropic Hormone; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use / Q000652:urine; D007223:Infant; D008297:Male; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D011279:Pregnanetriol / Q000652:urine
D011279:Pregnanetriol; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D006899:Mixed Function Oxygenases; D006854:Hydrocortisone